Techh.info/biomedtechnology hourly

Headlines

headlines texts
09.12.2019
19:55 ScienceDaily.comGenomic cut and paste using a Class 1 CRISPR system

Repairing faulty genes to prevent and cure disease is something researchers have been working towards for many years. While Class 2 CRISPR systems show great promise as gene editing tools in human cells, a research team has now demonstrated that a Cas3-based Class 1 CRISPR system may provide a more efficient and safer alternative, carrying out successful repair of a gene mutation responsible for Duchenne muscular dystrophy in patient-derived cells.

Скрыть анонс
19:16 Nature.ComA bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases

Скрыть анонс
19:09 Phys.orgCRISPR-resistant viruses build 'safe rooms' to shield genomes from DNA-dicing enzymes

Bacteria and the viruses that infect them are engaged in a molecular arms race as ancient as life itself. Evolution has equipped bacteria with an arsenal of immune enzymes, including CRISPR-Cas systems, that target and destroy viral DNA. But bacteria-killing viruses, also known as phages, have devised their own tools to help them outmaneuver even the most formidable of these bacterial defenses.

Скрыть анонс
18:11 SingularityHub.ComWill Cultured Bacon Be Delicious? A Dutch Startup Is Developing the First Lab-Grown Pork

The food chain has always worked roughly like this: sunlight feeds plants. Plants feed insects. Insects and plants feed animals. Plants and animals feed people. Then eventually—not to get too morbid here—people feed the Earth. Nothing like the circle of life, eh? But the traditional food chain’s getting shaken up. For starters, more and more […]

Скрыть анонс
17:10 Phys.orgGenomic cut and paste using a class 1 CRISPR system

Almost from the moment DNA was discovered, the ability to fix or remove disease-causing genes in affected patients has been something of a holy grail of medicine. Now that this goal is within reach, researchers are working to fine-tune the technology to ensure safe and effective gene editing with no unwanted downstream effects.

Скрыть анонс
17:08 News-Medical.NetAussies can have their health and eat meat too with new version of Mediterranean diet

Barbecued, stir-fried or roasted, there's no doubt that Aussies love their meat. Consuming on average nearly 100 kilograms of meat per person per year, Australians are among the top meat consumers worldwide.

Скрыть анонс
07:38 FT.com HealthGene therapy offers new vision to battle blindness

Single treatment using advanced microsurgery can cure condition for life

Скрыть анонс
07:38 FT.com HealthGene editing heralds new era of animal-to-human transplants

Biotechs race to serve patients stuck on waiting lists for organs

Скрыть анонс
07:38 FT.com HealthFT Health: Regenerative Medicine

Rapid advances in technology from bioelectronics to gene therapy offer new ways to treat many illnesses. But medical breakthroughs bring with them new questions of pricing, access and scientific responsibility

Скрыть анонс
07:38 FT.com HealthRegenerative medicine at a critical juncture

Margaret Hamburg on the intersection of science and responsibility

Скрыть анонс
07:38 FT.com HealthBiotech companies defend prices of one-off gene therapy

Latest treatments with price tags as high as $2m require new financing models

Скрыть анонс
07:38 FT.com ScienceGene therapy offers new vision to battle blindness

Single treatment using advanced microsurgery can cure condition for life

Скрыть анонс
07:38 FT.com ScienceGene editing heralds new era of animal-to-human transplants

Biotechs race to serve patients stuck on waiting lists for organs

Скрыть анонс
07:38 FT.com ScienceFT Health: Regenerative Medicine

Rapid advances in technology from bioelectronics to gene therapy offer new ways to treat many illnesses. But medical breakthroughs bring with them new questions of pricing, access and scientific responsibility

Скрыть анонс
07:38 FT.com SciencePioneering facility catapults UK to forefront of cell and gene therapy

Industry cluster aims to get inventions commercialised at home rather than in US

Скрыть анонс
07:38 FT.com ScienceRegenerative medicine at a critical juncture

Margaret Hamburg on the intersection of science and responsibility

Скрыть анонс
07:38 FT.com ScienceBiotech companies defend prices of one-off gene therapy

Latest treatments with price tags as high as $2m require new financing models

Скрыть анонс
08.12.2019
21:42 News-Medical.NetAdding venetoclax to transplant conditioning regimen shows promise in patients with myeloid cancers

For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients' bodies, a study led by Dana-Farber Cancer Institute researchers suggests.

Скрыть анонс
21:31 News-Medical.NetGenetic features of AML in older patients can predict outcomes after stem cell transplant

For older patients with acute myeloid leukemia, the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute and other research centers will report today at the 61st American Society of Hematology (ASH) Annual Meeting.

Скрыть анонс
20:38 News-Medical.NetNew startup aims to prevent reperfusion-related organ damage after liver transplant

Roughly 65 years ago, the first human organ transplant was successfully performed. A decade later, heart and liver transplants became possible. Now, a startup founded by researchers from the Medical University of South Carolina and elsewhere hopes to bring about the next major breakthrough.

Скрыть анонс
20:12 News-Medical.NetThe role of adenosine in neurodegeneration and brain regeneration

The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis.

Скрыть анонс
18:03 SingularityHub.ComWhy AI Will Be the Best Tool for Extending Our Longevity

Dmitry Kaminskiy speaks as though he were trying to unload everything he knows about the science and economics of longevity—from senolytics research that seeks to stop aging cells from spewing inflammatory proteins and other molecules to the trillion-dollar life extension industry that he and his colleagues are trying to foster—in one sitting. At the heart […]

Скрыть анонс
14:23 AzoRobotics.comAved Electronics Introduces Custom Designed Medical Robotics Battery Packs

Aved Electronics has introduced custom engineered, large format self-contained and portable modular battery packs for medical and mobility product OEMs requiring higher voltages. Aved Medical...

Скрыть анонс
07.12.2019
23:53 ScienceDaily.comRoot of childhood kidney cancer discovered

A fundamental change in our understanding of the childhood kidney cancer Wilms' tumor is on the horizon, after the discovery of its earliest genetic root by scientists. By comparing genome sequences from normal kidney tissue and tumors, the team identified patches of normal-looking kidney tissue that in fact carried DNA changes that cause Wilms' tumor.

Скрыть анонс
04:40 MedicalNewsToday.comMedical News Today: How effective are different hair transplant methods?

Hair transplants can be an effective treatment for hair loss. Here, we look at how the different types work, as well as their success rates and side effects.

Скрыть анонс
02:27 NYT HealthSurgeons Transplant a Testicle From One Brother to His Twin

The rare operation has implications for wounded soldiers, accident victims, cancer patients and those undergoing sex reassignment.

Скрыть анонс
01:44 ScienceDaily.com'Conductor' gene found in plant root stem cell 'orchestra'

Researchers lift the veil on the 'conductor' plant root stem cell gene that helps orchestrate and coordinate stem cell division of different root stem cell types, ensuring the harmonic communication necessary for plant growth and maintenance.

Скрыть анонс
06.12.2019
23:09 News-Medical.NetNew tool can rapidly reveal unintended changes made by CRISPR-directed gene editing

Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a new study in the Nature journal Communications Biology describes a new innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by a gene editing process.

Скрыть анонс
22:03 FierceBiotech.comHopkins team invents non-viral system for getting gene therapy into cells

Noninfectious viruses used to deliver gene therapy can still sometimes touch off dangerous immune responses. A team from Johns Hopkins Medicine has developed an alternative method for transporting large therapies into cells—including genes and even the gene-editing system CRISPR. It’s a polymer nano-container that biodegrades inside of cells.

Скрыть анонс
22:01 News-Medical.NetAuthors take in-depth look at risks associated with medical AI/ML systems

Artificial intelligence and machine learning (AI/ML) are increasingly transforming the healthcare sector. From spotting malignant tumours to reading CT scans and mammograms, AI/ML-based technology is faster and more accurate than traditional devices - or even the best doctors. But along with the benefits come new risks and regulatory challenges.

Скрыть анонс
20:55 Phys.orgGenetic typing of a bacterium with biotechnological potential

Pseudomonas putida is a bacterium occuring in soil, aquatic environments and plants. Although the virulence of Pseudomonas p.—the ability of the bacterium to infect its host and inflict a disease—is considered to be low, infection in severely ill patients can be lethal. P. putida strains (also called isolates) have been found in hospitals, e.g. in urine, blood or wound discharge from patients, and such clinical isolates have been found to display resistance to drugs. Now, Kohei Ogura from Kanazawa University and colleagues have performed gene sequencing for various P. putida isolates originating from both environmental and clinical sites.

Скрыть анонс
20:41 TechnologyReview.comBuyer beware of this $1 million gene therapy for aging

The offshore tests by a startup seek to lengthen people’s telomeres—and their lives.

Скрыть анонс
18:50 AzoRobotics.comAmputee Bonds with Son Thanks to 3D Printed Bionic Hand

For 21 years, Danny Florence has lived with one hand. But when he became a father, he decided to apply for an Open Bionics Hero Arm. With the help of the maxon driven prosthesis he can now build a...

Скрыть анонс
17:31 Phys.orgNew tool for rapidly analyzing CRISPR edits reveals frequent production of unintended edits

Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a study in Communications Biology describes a new innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by a gene editing process.

Скрыть анонс
17:17 Phys.orgNovel bioprinter shows potential to speed tissue engineering

The dream of tissue engineering is a computer-controlled manufacturing of complex and functional human tissue for potential organ regeneration or replacement.

Скрыть анонс
17:03 Phys.orgChina's failed gene-edited baby experiment proves we're not ready for human embryo modification

More than a year ago, the world was shocked by Chinese biophysicist He Jiankui's attempt to use CRISPR technology to modify human embryos and make them resistant to HIV, which led to the birth of twins Lulu and Nana.

Скрыть анонс
16:35 News-Medical.NetUAB bioprinter shows potential to accelerate tissue engineering

The dream of tissue engineering is a computer-controlled manufacturing of complex and functional human tissue for potential organ regeneration or replacement.

Скрыть анонс
15:29 News-Medical.NetStudy sheds light on how ‘junk DNA’ affects inherited cancer risk

A person’s risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as ‘junk DNA’, according to new research published in the British Journal of Cancer today (Friday).

Скрыть анонс
14:24 Phys.org'Conductor' gene found in plant root stem cell 'orchestra'

In a new paper, researchers at North Carolina State University lift the veil on the "conductor" plant root stem cell gene that helps orchestrate and coordinate stem cell division of different root stem cell types, ensuring the harmonic communication necessary for plant growth and maintenance.

Скрыть анонс
10:01 Nanowerk.comNovel bioprinter shows potential to speed tissue engineering (w/video)

Engineered tissue from a bioprinter has promise for organ regeneration or replacement.

Скрыть анонс
04:38 MedicalNewsToday.comMedical News Today: Prostate cancer: Home urine test could 'revolutionize diagnosis'

A recent study has investigated a simpler way of testing urine for prostate cancer. The new test would avoid the need for digital rectal examination.

Скрыть анонс
00:36 WhatReallyHappened.comThis mom got a $3 million hospital bill for her infant son's transplant surgery. How did U.S. healthcare costs get so high?

Скрыть анонс
05.12.2019
19:31 News-Medical.NetAdding post-transplant chemotherapy to standard treatment improves remission of allogeneic transplant patients

Investigators in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey compared outcomes for patients having undergone allogeneic stem cell transplant when post-transplant cyclophosphamide (PCy, a type of chemotherapy) was added as part of standard treatment to prevent disease through an immune response (immunoprophylaxis) than if this standard treatment was given alone.

Скрыть анонс
19:20 Reuters.com HealthFDA declines to approve Enzyvant regenerative therapy on manufacturing concerns

Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing.

Скрыть анонс
19:06 Reuters.com HealthFDA declines to approve Enzyvant's regenerative tissue therapy

Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing.

Скрыть анонс
18:36 Medscape.ComOur Failures Demand a New Approach to Cancer

Given the slow progress of the 'War on Cancer,' do we really expect that pouring ever-increasing amounts of money into the current treatment paradigm will provide a real solution?

Скрыть анонс
17:17 Phys.orgWith cellular blueprint for lungs, researchers look ahead to organ regeneration

Using sophisticated screening across animal species, researchers at Yale have created a cellular blueprint of the human lung that will make it easier to understand the design principles behind lung function and disease—and to bioengineer new lungs.

Скрыть анонс
11:07 Technology.orgWith cellular blueprint for lungs, Yale researchers look ahead to organ regeneration

Using sophisticated screening across animal species, researchers at Yale have created a cellular blueprint of the human lung

Скрыть анонс
05:26 CNNHow to live longer from what you eat

Want to live a long, healthy life? So do I. That's why for the past 15 years I've explored places around the world where people have done exactly that — places I dubbed "blue zones." And I'm convinced that the foods the people in these areas eat are a big part of their secret.

Скрыть анонс
01:13 Google news Sci/TechHeart in a Box: Device used to revive heart for transplant will increase donor pool, doctors say - CBS News

Heart in a Box: Device used to revive heart for transplant will increase donor pool, doctors say  CBS News

Скрыть анонс
01:00 Google news Sci/TechHeart in a Box: Device used to revive heart for transplant will increase donor pool, doctors say - CBS News

Heart in a Box: Device used to revive heart for transplant will increase donor pool, doctors say  CBS News

Скрыть анонс
00:59 News-Medical.NetA major step toward preventing GvHD in patients receiving bone marrow transplants

A drug used for rheumatoid arthritis has moved a step closer to FDA approval for a desperately needed new use.

Скрыть анонс
00:48 Google news Sci/TechChinese gene-edited twins created to be immune to HIV may have 'unintended mutations' - The Telegraph

Chinese gene-edited twins created to be immune to HIV may have 'unintended mutations'  The TelegraphChina gene-edited baby experiment 'may have created unintended mutations'  The GuardianScientists Slam CRISPR Babies Experiment After Findings Become Public For First Time  ScienceAlert‘Deliberate falsehood’: Scientists shred Chinese CRISPR babies experiment after leak of unpublished research  RTDesigner babies: Chinese scientist ‘may have created unintended mutations’  South China Morning PostView full coverage on Google News

Скрыть анонс
04.12.2019
23:27 ScienceDaily.comSome stress in early life extends lifespan

Some stress at a young age could actually lead to a longer life, new research shows.

Скрыть анонс
21:11 Phys.orgResearchers discover stress in early life extends lifespan

Some stress at a young age could actually lead to a longer life, new research shows.

Скрыть анонс
21:05 Nature.ComThe integrative biology of type 2 diabetes

Скрыть анонс
19:23 Nature.ComGene Therapy Arrives

Скрыть анонс
17:55 Technology.orgWill CRISPR-Cas9 Help Biohacker to Be Next Captain America

In the marvel universe, a short and thin guy named Rogers underwent a series of gene transformations and

Скрыть анонс
17:13 News-Medical.NetExperts condemn Chinese CRISPR babies research as original manuscript is made public

Scientists have criticized the gene-editing of the Chinese twins last year, following the first public release of the research.

Скрыть анонс
16:48 FierceBiotech.comOmeros hits endpoint in pivotal stem cell transplant study

A pivotal trial of Omeros’ narsoplimab in hematopoietic stem cell transplant patients has hit its primary endpoint. Omeros expects to use the data to win FDA approval, although secrecy around the design of the trial means there remains scope for skepticism about the results.

Скрыть анонс
16:21 Phys.orgBig data toolkit to mine the dark genome for precision medicine

EPFL researchers have developed Big Data tools for identifying new gene functions. The work identifies millions of connections between genes and their functions, and can facilitate the development of precision medicine.

Скрыть анонс
13:21 Nature.ComGene therapy is facing its biggest challenge yet

Скрыть анонс
10:33 Technology.orgDeveloping a new AI breast cancer diagnostic tool

Scientists are developing a new way to identify the unique chemical ‘fingerprints’ for different types of breast cancers.

Скрыть анонс
01:24 CNN HealthDoctors 'reanimate' heart for first-of-its-kind transplant in US

Doctors at Duke University Medical Center performed the first donation after circulatory death heart transplant on an adult in the United States on December 1.

Скрыть анонс
01:01 Reuters.com HealthDrinking milk does not appear to impact longevity

(Reuters Health) - People who consume lots of milk and cheese and yogurt may not necessarily live any longer than those who don't, a recent study suggests.

Скрыть анонс
03.12.2019
23:09 Google news Sci/TechAmazon AI generates medical records from patient-doctor conversations - Engadget

Amazon AI generates medical records from patient-doctor conversations  EngadgetWatch Amazon’s AWS re:Invent conference live right here  TechCrunchAmazon launches medical transcription service  ModernHealthcare.comAWS launches Amazon Transcribe Medical  MobiHealthNewsAWS CEO Andy Jassy's Love Of Music And Its Role At AWS re:Invent  CRN: The Biggest Tech News For Partners And The IT ChannelView full coverage on Google News

Скрыть анонс
23:08 News-Medical.NetZebrafish study supports accuracy of CRISPR-Cas9 gene editing tool

Along with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gene mutations in zebrafish. These results, published in Frontiers in Genetics, confirm previous data in animal models that the risk to the rest of the genome from gene editing is minimal.

Скрыть анонс
23:08 News-Medical.NetTransplant patients diagnosed with prostate cancer may not need to delay transplantation

Immunosuppressive medications – drugs given to organ transplant recipients so their bodies won't reject the donor organ - could weaken the immune system's ability to find and destroy cancer or fight infections that contribute to cancer.

Скрыть анонс
21:53 News-Medical.NetIsolated components of Saussurea have positive effect on bone tissue regeneration

Saussurea controversa is a perennial herbaceous plant that has been traditionally used by the people of the Far East, Siberia, Tibet, and Mongolia to treat liver, kidney, digestive tract, and locomotive diseases. Its dried leaves are sold in pharmacies because their decoction is widely used as a medicine against cold and bronchitis. To understand what substances this plant owes its medicinal properties to, a team of scientists from Siberian State Medical University and Tomsk Polytechnic University extracted individual components from the plant and determined their composition.

Скрыть анонс
21:42 Google news Sci/TechHeart from dead donor revived, transplanted into veteran in US first - Fox News

Heart from dead donor revived, transplanted into veteran in US first  Fox NewsMilitary veteran gets first heart transplant of its kind at Duke  ABC11Doctors brought a heart back to life in a transplant, the first of its kind in the US  msnNOWMilitary veteran gets first heart transplant of its kind at Duke Hospital  WTVD-TVUS doctors bring heart of deceased donor back to life for the first time  NewshubView full coverage on Google News

Скрыть анонс
20:58 Nature.ComDaily briefing: The unpublished CRISPR-babies papers

Скрыть анонс
20:25 Google news Sci/TechMilitary veteran gets first heart transplant of its kind at Duke Hospital - WTVD-TV

Military veteran gets first heart transplant of its kind at Duke Hospital  WTVD-TVView full coverage on Google News

Скрыть анонс
20:11 Google news Sci/TechMilitary veteran gets first heart transplant of its kind at Duke Hospital - WTVD-TV

Military veteran gets first heart transplant of its kind at Duke Hospital  WTVD-TVView full coverage on Google News

Скрыть анонс
19:26 ScienceDaily.comHow stem cells decide their identity

Several hundred different cell types of the adult human body are formed during embryonic development, starting from just a few identical stem cells. The differentiation potential of the cells is progressively restricted in the course of this process, causing changes in their morphology and functions.

Скрыть анонс
19:26 ScienceDaily.comNew approach to treating cystic fibrosis could lower risk of lung transplants and death

A new approach to treating people with cystic fibrosis (CF) has been shown to reduce inflammation, which has the potential to reduce the need for lung transplants and lower the risk of death.

Скрыть анонс
18:52 Phys.orgResearch team deciphers how stem cells decide their identity

A research team headed by Prof. Dr. Sebastian Arnold and Jelena Tosic from the Faculty of Medicine at the University of Freiburg has now succeeded in deciphering basic molecular control mechanisms by which stem cells decide which embryonic cell types to turn into. This is achieved at least partially through selective usage of the genes for each different cell type, despite the presence of the identical genetic information in every cell in the body. The scientists have published their findings in the journal Nature Cell Biology.

Скрыть анонс
17:58 Medscape.ComUterine Transplantation: Success and Failure

Just a few years ago we heard about the first baby to be born after uterine transplantation. But there's a downside.

Скрыть анонс
13:59 CNN HealthA 'blue zones' diet: Live longer from what you eat

For most of their lives, the world's super-agers have nourished their bodies with whole, plant-based foods, such as leafy vegetables, tubers, nuts, beans and whole grains. And they ate meat fewer than five times monthly.

Скрыть анонс
13:08 TechnologyReview.comOpinion: We need to know what happened to CRISPR twins Lulu and Nana

The unpublished research paper by He Jiankui about the creation of the babies shows proof of attempted gene editing gone awry.

Скрыть анонс
13:08 TechnologyReview.comWhy the paper on the CRISPR babies stayed secret for so long

The report describing the creation of the world’s first gene-edited babies creates an ethical quandary for scientific journals.

Скрыть анонс
13:08 TechnologyReview.comChina’s CRISPR babies: Read exclusive excerpts from the unseen original research

He Jiankui’s manuscript shows how he ignored ethical and scientific norms in creating the gene-edited twins Lulu and Nana.

Скрыть анонс
12:42 FierceBiotech.comAstellas inks $3B Audentes buyout to expand in gene therapy

Astellas Pharma is set to buy Audentes Therapeutics for $3 billion. The deal will enable Astellas to set up a new genetic regulation unit spearheaded by a neuromuscular disease gene therapy that is set to be submitted for approval next year.

Скрыть анонс
09:40 TechInvestorNews.comXiaomi Mi Watch Apple Watch clone now works with Apple iPhone (Ewdison Then/SlashGear)

Ewdison Then / SlashGearXiaomi Mi Watch Apple Watch clone now works with Apple iPhone - Chinese brands have had the reputation of being copycats. Chinese phone makers have indeed been guilty of that for a time but, for the past years, they have been working hard to change their public image but, last October, Xiaomi single-handedly undid much of that. Its hard not to see ...

Скрыть анонс
04:41 MedicalNewsToday.comMedical News Today: Green spaces in cities can help people live longer

A large meta-analysis of existing studies now suggests that green spaces may protect the residents of urban areas from premature death.

Скрыть анонс
04:41 MedicalNewsToday.comMedical News Today: Parks with irregular shapes may boost longevity

A new study finds that parks with complex, irregular shapes and more access points are associated with a lower risk of premature mortality.

Скрыть анонс
04:41 MedicalNewsToday.comMedical News Today: Stem cell discovery could improve treatments for leukemia, other diseases

Scientists have found a way to boost blood stem cell self-renewal in the lab. The finding could improve treatments for leukemia and other blood diseases.

Скрыть анонс
01:35 News-Medical.NetStem cell therapy shows promise for the first time in spinal cord injury

Researchers have published the results of their work where stem cell therapy has shown promise in a case of spinal cord injury. The results of their case study were published in the latest issue of the journal Mayo Clinic Proceedings last week.

Скрыть анонс
02.12.2019
22:31 TechInvestorNews.comAmazon introduces AI-powered note-taking to help doctors focus on patients’ needs (Darren Allan/TechRadar)

Darren Allan / TechRadarAmazon introduces AI-powered note-taking to help doctors focus on patients’ needs - Speech-to-text system is very accurate and can deliver transcriptions straight into the patients medical record. Over at AWS re:Invent 2019, Amazon has launched a new machine learning-powered service which can transcribe conversations between doctors and patients, effectively creating a digital copy of those consultations with relative ease. Amazon Transcribe Medical ...

Скрыть анонс
21:40 TechInvestorNews.comAmazon AI generates medical records from patient-doctor conversations (Engadget)

EngadgetAmazon AI generates medical records from patient-doctor conversations - Amazon believes its latest Web Services tool will help doctors spend more time with their patients. The tool, called Amazon Transcribe Medical, allows doctors to easily transcribe patient conversations and add those interactions to someones medical records with the help of deep learning software. According to Matt Wood, vice president ...

Скрыть анонс
20:06 News-Medical.NetPurification scheme allows collection of elusive blood stem cells from zebrafish

Hematopoietic stem cells are multipotent cells that can develop into every type of blood cell in the body.

Скрыть анонс
16:34 TechInvestorNews.comPrivacy Concerns About Training AI On Medical Data, Nvidia Thinks Clara is the Answer (Conor Reynolds/Computer Business Review)

Conor Reynolds / Computer Business ReviewPrivacy Concerns About Training AI On Medical Data, Nvidia Thinks Clara is the Answer - The process repeats until the AI model reaches its desired accuracy. The post Privacy Concerns About Training AI On Medical Data, Nvidia Thinks Clara is the Answer appeared first on Computer Business Review. This week at the annual conference of the Radiological Society of North America, machine learning and AI ...

Скрыть анонс
16:34 Phys.orgHarnessing the power of CRISPR in space and time

Researchers in Vienna from Ulrich Elling's laboratory at IMBA—Institute of Molecular Biotechnology of the Austrian Academy of Sciences—in collaboration with the Vienna BioCenter Core Facilities have developed a revolutionary CRISPR technology called "CRISPR-Switch," which enables unprecedented control of the CRISPR technique in both space and time.

Скрыть анонс
16:21 FierceBiotech.comCyrus, the Broad team up to make in vivo CRISPR use safer

Cyrus Biotechnology has teamed up with the Broad Institute to optimize CRISPR for use in humans. Feng Zhang, who had a hand in developing CRISPR, will serve as the Broad’s principal investigator for the collaboration. 

Скрыть анонс
12:44 Technology.orgNew principle for activation of cancer genes discovered

Researchers have long known that some genes can cause cancer when overactive, but exactly what happens inside the

Скрыть анонс
03:02 ScienceDaily.comHome urine test for prostate cancer could revolutionize diagnosis

A new home urine test for prostate cancer could revolutionize diagnosis -- according to new research. As well as diagnosing aggressive prostate cancer, the test predicts whether patients will require treatment up to five years earlier than standard clinical methods. It also means that men don't have to come into the clinic to provide a urine sample -- or have to undergo an uncomfortable rectal examination.

Скрыть анонс
30.11.2019
17:35 WhatReallyHappened.comThe Hope of the Democrat Party: Michael Bloomberg Says He’ll Take Money from the Poor Because “Then the Poor Will Live Longer” (VIDEO)

Former New York City Mayor Michael Bloomberg is the latest Democrat to jump in the primary race to save the party from itself. It didn’t take long though for Bloomberg to promise to tax the poor “so they will live longer.”

Скрыть анонс
14:56 Google news Sci/TechWhen a car delivering a heart for transplant got a flat, 2 Illinois state police came to the rescue - CNN

When a car delivering a heart for transplant got a flat, 2 Illinois state police came to the rescue  CNNIllinois State Troopers help deliver a heart after an organ transplant vehicle broke down  KMOV St. LouisDonor heart saved by troopers after transplant team gets stranded  msnNOWTroopers Help Medical Team Get Heart To Transplant Patient  Patch.comDonor heart, stranded transplant team rescued by troopers  ABC NewsView full coverage on Google News

Скрыть анонс
13:38 Google news Sci/TechWhen a car delivering a heart for transplant got a flat, 2 Illinois state police came to the rescue - CNN

When a car delivering a heart for transplant got a flat, 2 Illinois state police came to the rescue  CNNIllinois State Troopers help deliver a heart after an organ transplant vehicle broke down  KMOV St. LouisDonor heart saved by troopers after transplant team gets stranded  msnNOWTroopers Help Medical Team Get Heart To Transplant Patient  Chicago, IL PatchDonor heart, stranded transplant team rescued by troopers  ABC NewsView full coverage on Google News

Скрыть анонс
29.11.2019
18:56 Nature.Com Targeted stem-cell attack could make transplants safer

Скрыть анонс
16:45 WhatReallyHappened.comGoogle’s entry into the electronic medical records biz has put data of 50 million Americans at risk, whistleblower warns

Скрыть анонс
First← Previous12345678910Previous →Last